ALK-Abelló A/S (0OIR.IL)
| Previous close | 149.45 |
| Open | 0.00 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 0.00 - 0.00 |
| 52-week range | |
| Volume | |
| Avg. volume | 84,541 |
| Market cap | 15.949B |
| Beta (5Y monthly) | 0.30 |
| PE ratio (TTM) | 49.35 |
| EPS (TTM) | 1.61 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 16 Mar 2017 |
| 1y target est | N/A |
GlobeNewswireSix-month interim report (Q2) 2023
ALK delivers 11% revenue growth with operating profit up 120% in Q2 (unaudited) ALK’s revenue grew by 11% in Q2 2023, driven by 17% growth in tablet sales and double-digit growth in combined SCIT/SLIT-drops sales. Operating profit (EBIT) increased by 120% in local currencies on sales growth and gross margin improvements. Q2 2023 financial highlights Comparative figures for Q2 2022 are shown in brackets. Revenue growth rates are stated in local currencies, unless otherwise indicated Revenue incre
- GlobeNewswire
Release date of six-month interim report (Q2) 2023 for ALK and audio cast
On Thursday, 24 August 2023 ALK (ALKB:DC / OMX: ALK B / AKBLF) releases its six-month interim report (Q2) 2023. ALK will host a meeting for analysts and institutional investors that day at 1.30pm (CEST) at which Management will review the financial results, the outlook and answer questions. The meeting will be audio cast live on our website https://ir.alk.net, where the related presentation will be available shortly before the meeting begins. Participants in the conference call are kindly reques
- GlobeNewswire
President & CEO Carsten Hellmann to step down end 2023. Peter Halling appointed as his successor
ALK (ALKB:DC / OMX: ALK B / AKBLF) today announced that Carsten Hellman will step down as President & CEO at the end of 2023. He will be succeed by Peter Halling no later than 1 January 2024. The Board of Directors and Carsten Hellmann have reached a mutual agreement, that Carsten will step down as President & CEO of ALK at the end of 2023 to pursue a non-executive career after leading the successful development and positioning of ALK on the global allergy market for almost seven years. Carsten
